Yuhan’s Licensed-out Disc Treatment to Go on Phase 3 Trial in U.S.

SEOUL, April 11 (Korea Bizwire) — South Korean pharmaceutical firm Yuhan Corp. said Monday its degenerative disc drug licensed out to an American drug company will go on Phase 3 clinical trial in the United States. U.S.-based Spine BioPharma has been given permission from the U.S. Food and Drug Administration to bypass the second phase [...]